Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 416.20
Change Today -29.20 / -6.56%
Volume 1.5K
EXEN On Other Exchanges
Tel Aviv
As of 10:24 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott L. Friedman M.D.

Member of Scientific Advisory Board, Exalenz Bioscience Ltd
AgeTotal Calculated CompensationThis person is connected to 41 board members in 4 different organizations across 5 different industries.

See Board Relationships


Dr. Scott L. Friedman, M.D., serves as the Chief of the Division of Liver Diseases and Professor of Medicine at Mount Sinai School of Medicine in New York. At Mount Sinai School of Medicine in New York, Dr. Friedman is responsible for the discovery of a novel tumor suppressor gene, KLF6 that is inactivated in a number of human cancers, including primary liver cancer. He has performed pioneering research into the underlying causes of scarring, or fibrosis, associated ...

Read Full Background

Corporate Headquarters*

4 Ha’maayan Street
Modiin, -- 71700


Phone: 972 8 973 7500
Fax: 972 8 973 7501

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education 1979
Mount Sinai School Of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEN:IT 416.20 -29.20


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXALENZ BIOSCIENCE LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at